UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Updated UK Recommendations for HER2 assessment in breast cancer

Journal of clinical pathology, 2015-02, Vol.68 (2), p.93-99

2015

Volltextzugriff (PDF)

PD-L1 testing for lung cancer in the UK: recognizing the challenges for implementation

Histopathology, 2016-08, Vol.69 (2), p.177-186

2016

Volltextzugriff (PDF)

ALK Immunohistochemistry in NSCLC: Discordant Staining Can Impact Patient Treatment Regimen

Journal of thoracic oncology, 2016-12, Vol.11 (12), p.2241-2247

2016

Volltextzugriff (PDF)

Breast cancer biomarkers in clinical testing: analysis of a UK national external quality assessment scheme for immunocytochemistry and in situ hybridisation database containing results from 199 300 patients

The journal of pathology. Clinical research, 2018-10, Vol.4 (4), p.262-273

2018

Volltextzugriff (PDF)

Synantocytes: the fifth element

Journal of anatomy, 2005-12, Vol.207 (6), p.695-706

2005

Volltextzugriff (PDF)

Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine - Part 2: Immunohistochemistry Test Performance Characteristics

Applied immunohistochemistry & molecular morphology, 2017-02, Vol.25 (2), p.79-85

2017

Volltextzugriff (PDF)

Selective enhancement of gene transfer by steroid-mediated gene delivery

Nature biotechnology, 2001-12, Vol.19 (12), p.1155-1161

2001

Volltextzugriff (PDF)

TCH346 prevents motor symptoms and loss of striatal FDOPA uptake in bilaterally MPTP-treated primates

Neurobiology of disease, 2003-11, Vol.14 (2), p.205-217

2003

Volltextzugriff (PDF)

Standardization of positive controls in diagnostic immunohistochemistry: recommendations from the International Ad Hoc Expert Committee

Applied immunohistochemistry & molecular morphology, 2015-01, Vol.23 (1), p.1-18

2015

Volltextzugriff (PDF)

Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine. Part 3: Technical Validation of Immunohistochemistry (IHC) Assays in Clinical IHC Laboratories

Applied immunohistochemistry & molecular morphology, 2017-03, Vol.25 (3), p.151-159

2017

Volltextzugriff (PDF)

Morphology of perineuronal nets in tenascin-R and parvalbumin single and double knockout mice

Brain research, 2000-05, Vol.864 (1), p.142-145

2000

Volltextzugriff (PDF)

Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine: Part 1: Fit-for-Purpose Approach to Classification of Clinical Immunohistochemistry Biomarkers

Applied immunohistochemistry & molecular morphology, 2017-01, Vol.25 (1), p.4-11

2017

Volltextzugriff (PDF)

Breast cancer biomarkers in clinical testing: analysis of a UK NEQAS ICC & ISH database containing results from 199 300 patients

The journal of pathology. Clinical research, 2020-07, Vol.6 (3), p.227-227

2020

Volltextzugriff (PDF)

Standardization of negative controls in diagnostic immunohistochemistry: recommendations from the international ad hoc expert panel

Applied immunohistochemistry & molecular morphology, 2014-04, Vol.22 (4), p.241-252

2014

Volltextzugriff (PDF)

HER2 testing in the UK: recommendations for breast and gastric in-situ hybridisation methods

Journal of clinical pathology, 2011-08, Vol.64 (8), p.649-653

2011

Volltextzugriff (PDF)

Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine: Part 4: Tissue Tools for Quality Assurance in Immunohistochemistry

Applied immunohistochemistry & molecular morphology, 2017-04, Vol.25 (4), p.227-230

2017

Volltextzugriff (PDF)

Abstract P5-10-03: Audit of the accuracy of immunohistochemical (IHC) testing of HER2 negative status of breast cancer in the United Kingdom

Cancer research (Chicago, Ill.), 2015-05, Vol.75 (9_Supplement), p.P5-P5-10-03

2015

Volltextzugriff (PDF)

Potential for false-positive staining with a rabbit monoclonal antibody to progesterone receptor (SP2): findings of the UK National External Quality Assessment Scheme for Immunocytochemistry and FISH highlight the need for correct validation of antibodies on introduction to the laboratory

American journal of clinical pathology, 2008-03, Vol.129 (3), p.398-409

2008

Volltextzugriff (PDF)

A UK NEQAS ISH Multicenter Ring Study Using the Ventana HER2 Dual-Color ISH Assay

American journal of clinical pathology, 2011, Vol.135 (1), p.157-162

2011

Volltextzugriff (PDF)

Laser Technologies in Toxicopathology

Toxicologic pathology, 2002-01, Vol.30 (1), p.11-14

2002

Volltextzugriff (PDF)

Chromogenic In Situ Hybridization

American journal of clinical pathology, 2009-10, Vol.132 (4), p.514-520

2009

Volltextzugriff (PDF)

External Quality Assurance of HER2 FISH and ISH Testing : Three Years of the UK National External Quality Assurance Scheme

American journal of clinical pathology, 2009, Vol.131 (1), p.106-111

2009

Volltextzugriff (PDF)

Chromogenic In Situ Hybridization: A Multicenter Study Comparing Silver In Situ Hybridization With FISH

American journal of clinical pathology, 2009-10, Vol.132 (4), p.514-520

2009

Volltextzugriff (PDF)

External quality assurance of HER2 fluorescence in situ hybridisation testing: results of a UK NEQAS pilot scheme

Journal of clinical pathology, 2007-07, Vol.60 (7), p.816-819

2007

Volltextzugriff (PDF)

The identification of a small but significant subset of patients still targetable with anti-HER2 inhibitors when affected by triple negative breast carcinoma

Journal of cancer research and clinical oncology, 2013-09, Vol.139 (9), p.1563-1568

2013

Volltextzugriff (PDF)

1 – 25 von 42

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(32)

Publikationsform

Sprache

Englisch
(42)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(32)
Science & Technology
(32)
Pathology
(22)
Humans
(21)
Immunohistochemistry
(12)
Animals
(11)
Biological And Medical Sciences
(11)
Quality Control
(11)
Female
(10)
Medical Sciences
(10)
Quality Assurance
(9)
Anatomy & Morphology
(8)
Medical Laboratory Technology
(8)
Breast Cancer
(7)
Neurosciences
(7)
Tumors
(7)
Her2
(6)
Immunohistochemistry - Standards
(6)
Investigative Techniques, Diagnostic Techniques
(6)
Neurosciences & Neurology
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Updated UK Recommendations for HER2 assessment in breast cancer

PD-L1 testing for lung cancer in the UK: recognizing the challenges for implementation

ALK Immunohistochemistry in NSCLC: Discordant Staining Can Impact Patient Treatment Regimen

Breast cancer biomarkers in clinical testing: analysis of a UK national external quality assessment scheme for immunocytochemistry and in situ hybridisation database containing results from 199 300 patients

Synantocytes: the fifth element

Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine - Part 2: Immunohistochemistry Test Performance Characteristics

Selective enhancement of gene transfer by steroid-mediated gene delivery

TCH346 prevents motor symptoms and loss of striatal FDOPA uptake in bilaterally MPTP-treated primates

Standardization of positive controls in diagnostic immunohistochemistry: recommendations from the International Ad Hoc Expert Committee

Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine. Part 3: Technical Validation of Immunohistochemistry (IHC) Assays in Clinical IHC Laboratories

Morphology of perineuronal nets in tenascin-R and parvalbumin single and double knockout mice

Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine: Part 1: Fit-for-Purpose Approach to Classification of Clinical Immunohistochemistry Biomarkers

Breast cancer biomarkers in clinical testing: analysis of a UK NEQAS ICC & ISH database containing results from 199 300 patients

Standardization of negative controls in diagnostic immunohistochemistry: recommendations from the international ad hoc expert panel

HER2 testing in the UK: recommendations for breast and gastric in-situ hybridisation methods

Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine: Part 4: Tissue Tools for Quality Assurance in Immunohistochemistry

Abstract P5-10-03: Audit of the accuracy of immunohistochemical (IHC) testing of HER2 negative status of breast cancer in the United Kingdom

Potential for false-positive staining with a rabbit monoclonal antibody to progesterone receptor (SP2): findings of the UK National External Quality Assessment Scheme for Immunocytochemistry and FISH highlight the need for correct validation of antibodies on introduction to the laboratory

A UK NEQAS ISH Multicenter Ring Study Using the Ventana HER2 Dual-Color ISH Assay

Laser Technologies in Toxicopathology

Chromogenic In Situ Hybridization

External Quality Assurance of HER2 FISH and ISH Testing : Three Years of the UK National External Quality Assurance Scheme

Chromogenic In Situ Hybridization: A Multicenter Study Comparing Silver In Situ Hybridization With FISH

External quality assurance of HER2 fluorescence in situ hybridisation testing: results of a UK NEQAS pilot scheme

The identification of a small but significant subset of patients still targetable with anti-HER2 inhibitors when affected by triple negative breast carcinoma

Suchergebnisse filtern